TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30782894

Group type: EXPERIMENTAL
Intervention: Basic Pelvic Floor Muscle Training (PFMT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Biofeedback-mediated Pelvic Floor Muscle Training (PFMT)
Number of subjects: 40
Study: 29641819

Group type: EXPERIMENTAL
Intervention: Social worker-led palliative care intervention
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 50
Study: 26197031

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg · d(‐1) for 6 months
Number of subjects: 418

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 418
Study: 24512477

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) program
Number of subjects: 18
Study: 22446975

Group type: EXPERIMENTAL
Intervention: Assets‐Getting To Outcomes (AGTO) intervention
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (not using AGTO)
Number of subjects: 12
Study: 20233153

Group type: EXPERIMENTAL
Intervention: Weight maintenance interventions following family-based behavioral weight loss treatment for HIGH children (n = 71)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Weight maintenance interventions following family-based behavioral weight loss treatment for LOW children (n = 130)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Parent psychopathology
Number of subjects: 201
Study: 17376109

Group type: EXPERIMENTAL
Intervention: Noonan syndrome group (NS)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study: 15705119

Group type: EXPERIMENTAL
Intervention: Low-intensity acenocoumarol (target INR 1.5 to 2.0)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 19
Study: 11680026

Group type: EXPERIMENTAL
Intervention: Community-based participatory research (CBPR) partnership involving community-based organizations, a local health department, academia, and an integrated health care system.
Number of subjects: 0
Study: 9258760

Group type: EXPERIMENTAL
Intervention: OsteoDyne's Hip Positioner System (HPS)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard hip positioner (Hologic)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard hip positioner (Lunar)
Number of subjects: 70
Study: 8502770

Group type: EXPERIMENTAL
Intervention: Convoluted foam overlay
Number of subjects: 84

Group type: COMPARATOR
Intervention: Solid foam overlay
Number of subjects: 84
Study: 3319817

Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg sublingually
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 2806274

Group type: EXPERIMENTAL
Intervention: Telebrix Gastro (ioxithalamate)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Gastrografin (amidotrizoate)
Number of subjects: 100
Study: 5683581

Group type: EXPERIMENTAL
Intervention: Iron plus 330 mug. of folic acid a day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iron alone
Number of subjects: 0
Study: 31280074

Group type: EXPERIMENTAL
Intervention: Inpatient energy management education (IEME)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Progressive muscle relaxation (PMR)
Number of subjects: 47
Study: 29206136

Group type: EXPERIMENTAL
Intervention: Diascorea extracts (12 mg/dose, 2 sachets daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 25710190

Group type: EXPERIMENTAL
Intervention: Red Bull (9.4 mL/kg body mass containing 3 mg/kg body mass caffeine)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Anhydrous caffeine (3 mg/kg body mass in capsule form)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 23105124

Group type: EXPERIMENTAL
Intervention: Powered bone marrow biopsy device (OnControl())
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard manual device (TRAP Hospital System)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both devices (with sedation)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both devices (no sedation)
Number of subjects: 50
Study: 22137516

Group type: EXPERIMENTAL
Intervention: BIS‐guided target‐controlled infusion of propofol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Manual control of propofol
Number of subjects: 40
Study: 19384758

Group type: EXPERIMENTAL
Intervention: Acute anterior uveitis (AAU) eyes
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy eyes (control)
Number of subjects: 20
Study: 17059650

Group type: EXPERIMENTAL
Intervention: Telemedicine continence programme (TCP)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional outpatient continence service (CS)
Number of subjects: 58
Study: 14759561

Group type: EXPERIMENTAL
Intervention: GLP-1 (1.2 pmol kg(‐1) min(‐1))
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (NaCl)
Number of subjects: 17
Study: 11549203

Group type: EXPERIMENTAL
Intervention: IL-2 alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IL-2 plus lymphokine-activated killer cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IL-2 plus IFN alpha
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tumour-infiltrating lymphocytes, IL-2 and IFN alpha
Number of subjects: 0

Group type: COMPARATOR
Intervention: Systemic chemotherapy
Number of subjects: 0
Study: 9294097

Group type: EXPERIMENTAL
Intervention: Nonpregnant fertile women (group 1)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Nonpregnant women with RSA (group 2)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Healthy pregnant women (group 3)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Pregnant women with RSA (group 4)
Number of subjects: 78
Study: 8336878

Group type: EXPERIMENTAL
Intervention: Pliable Silastic cup
Number of subjects: 100

Group type: COMPARATOR
Intervention: Rigid Malmström cup
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both cups
Number of subjects: 100
Study: 3534261

Group type: EXPERIMENTAL
Intervention: Diflunisal
Number of subjects: 34

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 34
Study: 28801001

Group type: EXPERIMENTAL
Intervention: Home-based palliative heart failure (HPHF) program
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84
Study: 27441869

Group type: EXPERIMENTAL
Intervention: Tailored website
Number of subjects: 1065

Group type: COMPARATOR
Intervention: Nontailored website
Number of subjects: 1065
Study: 24817819

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75% plus perineural dexamethasone 4 mg (group Dperi)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75% plus intravenous dexamethasone 4 mg (group Div)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Ropivacaine 0.75% (group C)
Number of subjects: 39
Study: 21967191

Group type: EXPERIMENTAL
Intervention: High-frequency rTMS (5 Hz)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham placebo
Number of subjects: 20
Study: 20205574

Group type: EXPERIMENTAL
Intervention: Central PA mobilization
Number of subjects: 60

Group type: COMPARATOR
Intervention: Random mobilization
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both mobilization techniques
Number of subjects: 60
Study: 18258393

Group type: EXPERIMENTAL
Intervention: Emulgels containing flurbiprofen
Number of subjects: 0
Study: 16787138

Group type: EXPERIMENTAL
Intervention: PDE3 inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy with beta-adrenergic receptor antagonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PDE5 inhibitors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other vasodilators
Number of subjects: 0
Study: 12841882

Group type: EXPERIMENTAL
Intervention: Vaginal ring releasing estradiol acetate (50 microg/day) plus placebo tablets
Number of subjects: 159

Group type: COMPARATOR
Intervention: Oral estradiol (1 mg/day) plus placebo vaginal ring
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Vaginal ring
Number of subjects: 159
Study: 10648342

Group type: EXPERIMENTAL
Intervention: Ramosetron 0.15 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ramosetron 0.3 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ramosetron 0.6 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 9709353

Group type: COMPARATOR
Intervention: Closed chest compressions on the ground
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Closed chest compressions in the MB 510 ambulance
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Closed chest compressions in the MB 310 ambulance
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Closed chest compressions in the VW T4 ambulance
Number of subjects: 10
Study: 8325043

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate via 'Autohaler' inhalation device
Number of subjects: 36

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate via conventional metered dose inhaler
Number of subjects: 36
Study: 3822496

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine infusion (5 mg/kg body weight)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 0
Study: 31600349

Group type: EXPERIMENTAL
Intervention: Silymarin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28611089

Group type: EXPERIMENTAL
Intervention: Free and convenient access to a carefully selected list of 125 essential medicines (based on the WHO's Model List of Essential Medicines)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual means of medicine access
Number of subjects: 0
Study: 26132939

Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg
Number of subjects: 3731

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3731
Study: 23244366

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Interpersonal Therapy (IPT)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control (No sudden gains)
Number of subjects: 67
Study: 22080025

Group type: EXPERIMENTAL
Intervention: Red light (R)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Fluorescent light (DR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Natural daylight (DF)
Number of subjects: 120
Study: 18573394

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft surgery
Number of subjects: 164

Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 164
Study: 16543745

Group type: EXPERIMENTAL
Intervention: Substance misuse with psychiatric concurrent disorders
Number of subjects: 0

Group type: COMPARATOR
Intervention: Substance misuse only
Number of subjects: 0
Study: 14507560

Group type: EXPERIMENTAL
Intervention: 4 mg of 0.5% hyperbaric bupivacaine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 6 mg of 0.5% hyperbaric bupivacaine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 8 mg of 0.5% hyperbaric bupivacaine
Number of subjects: 90
Study: 10713626

Group type: EXPERIMENTAL
Intervention: Peripheral Blood Stem Cell (PBSC) collection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bone Marrow (BM) collection
Number of subjects: 40
Study: 8680049

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 0
Study: 1642526

Group type: EXPERIMENTAL
Intervention: Supine-lying back extension (SBE) exercise
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Prone-lying back extension (PBE) exercise
Number of subjects: 34

Group type: COMPARATOR
Intervention: No exercise training (Control)
Number of subjects: 34
Study: 6844470

Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Weekly sessions with one therapist
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Monthly sessions with one therapist
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Two therapists (male/female pair)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: One therapist (female)
Number of subjects: 48
Study: 30221566

Group type: EXPERIMENTAL
Intervention: PRG-loaded NVTEs vaginal gel
Number of subjects: 0
Study: 30286920

Group type: COMPARATOR
Intervention: None hypoglycemia
Number of subjects: 1984

Group type: EXPERIMENTAL
Intervention: Mild hypoglycemia
Number of subjects: 1984

Group type: EXPERIMENTAL
Intervention: Severe hypoglycemia
Number of subjects: 1984

Group type: EXPERIMENTAL
Intervention: Less than weekly hypoglycemia
Number of subjects: 1984

Group type: EXPERIMENTAL
Intervention: Greater than or equal to weekly hypoglycemia
Number of subjects: 1984
Study: 27022635

Group type: EXPERIMENTAL
Intervention: 4.0 mm-long implants
Number of subjects: 150

Group type: COMPARATOR
Intervention: 8.5 mm-long implants
Number of subjects: 150
Study: 25124505

Group type: EXPERIMENTAL
Intervention: Group anger management treatment (AMT)
Number of subjects: 109
Study: 22011557

Group type: EXPERIMENTAL
Intervention: Ivabradine 15 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Metoprolol 50 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ivabradine in long-term β-blocker therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Metoprolol in long-term β-blocker therapy
Number of subjects: 120
Study: 19284124

Group type: EXPERIMENTAL
Intervention: Seated in the direction of the long axis of the table, heels resting on the table
Number of subjects: 168

Group type: COMPARATOR
Intervention: Seated perpendicular to the long axis of the table, legs hanging from the table
Number of subjects: 168

Group type: COMPARATOR
Intervention: Left lateral decubitus position
Number of subjects: 168
Study: 17465661

Group type: EXPERIMENTAL
Intervention: SEP Clearfil S3 Bond after one light cure
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: SEP Clearfil S3 Bond after two light cures
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Adper Prompt L‐Pop after one light cure
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Adper Prompt L‐Pop after two light cures
Number of subjects: 75

Group type: COMPARATOR
Intervention: Transbond Plus
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: SEP Adper Prompt L‐Pop
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: SEP Clearfil S3 Bond light cured together with adhesive
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: SEP Clearfil S3 Bond light cured separately from adhesive
Number of subjects: 75
Study: 15074085

Group type: EXPERIMENTAL
Intervention: Angelica Injection (AI)
Number of subjects: 1404

Group type: COMPARATOR
Intervention: Compound salvia
Number of subjects: 1404

Group type: COMPARATOR
Intervention: Low molecular dextran injection
Number of subjects: 1404
Study: 12083500

Group type: EXPERIMENTAL
Intervention: Sulodexide
Number of subjects: 235

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235
Study: 9534081

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (75 +/- 8% CHO, n = 6)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (7 +/- 4% CHO, n = 6)
Number of subjects: 12
Study: 12799862

Group type: EXPERIMENTAL
Intervention: Verum acupuncture (correct point location, normal prick depth, elicitation of needle sensation)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control acupuncture (points far from acupuncture points, superficial prick technique, no needle sensation)
Number of subjects: 81
Study: 2125546

Group type: EXPERIMENTAL
Intervention: Monophasic preparation (150 micrograms LNG and 30 micrograms EE)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Triphasic preparation (low doses of LNG and EE in various proportions)
Number of subjects: 45

Group type: COMPARATOR
Intervention: IUD users
Number of subjects: 45
Study: 6793373

Group type: EXPERIMENTAL
Intervention: Sublingual nitroglycerin 0.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral nitroglycerin 6.5 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo tablet
Number of subjects: 0
Study: 29087367

Group type: EXPERIMENTAL
Intervention: PVP plus I seed
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: PVP plus RT
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: PVP plus RFA
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: PVP plus ZA
Number of subjects: 169
Study: 29197834

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg per day
Number of subjects: 200

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 200
Study: 25699296

Group type: EXPERIMENTAL
Intervention: Bovine bone graft‐1
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Bovine bone graft‐2
Number of subjects: 8
Study: 25223171

Group type: EXPERIMENTAL
Intervention: Bushen Tiaojing Recipe (BTR) + controlled ovarian hyperstimulation (COH)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Controlled ovarian hyperstimulation (COH) alone
Number of subjects: 60
Study: 23217036

Group type: EXPERIMENTAL
Intervention: Community-based health management
Number of subjects: 2400

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2400
Study: 20181815

Group type: EXPERIMENTAL
Intervention: 50 microg Se-yeast/d
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 100 microg Se-yeast/d
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 200 microg Se-yeast/d
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 50 microg Se-enriched onions/d
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control (unenriched onion meals)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: All selenium intervention groups
Number of subjects: 119
Study: 16802196

Group type: EXPERIMENTAL
Intervention: High-dose alcohol
Number of subjects: 115

Group type: COMPARATOR
Intervention: Sober participants
Number of subjects: 115

Group type: COMPARATOR
Intervention: Mildly intoxicated participants
Number of subjects: 115
Study: 15725050

Group type: EXPERIMENTAL
Intervention: Respimat Soft Mist Inhaler (SMI)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Hydrofluoroalkane metered dose inhaler (HFA-MDI)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Respimat SMI
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Respimat SMI and HFA-MDI
Number of subjects: 245
Study: 12011296

Group type: EXPERIMENTAL
Intervention: Pramipexole (PPX) at doses of 1.5 mg/d and 4.5 mg/d
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pramipexole (PPX)
Number of subjects: 0
Study: 10216808

Group type: EXPERIMENTAL
Intervention: Eprosartan (200 mg b.i.d. to 300 mg b.i.d.)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Enalapril (5 mg o.d. to 20 mg o.d.)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Eprosartan + Hydrochlorothiazide (HCTZ) (12.5‐25 mg o.d. added if SitDBP > or = 90 mmHg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Enalapril + Hydrochlorothiazide (HCTZ)
Number of subjects: 40
Study: 7797830

Group type: EXPERIMENTAL
Intervention: ursodeoxycholic acid
Number of subjects: 56

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 56
Study: 2129650

Group type: EXPERIMENTAL
Intervention: enprostil 70 micrograms b.d.
Number of subjects: 98

Group type: COMPARATOR
Intervention: ranitidine 150 mg b.d.
Number of subjects: 98
Study: 359216

Group type: EXPERIMENTAL
Intervention: Nefopam 30 mg
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Nefopam 60 mg
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Nefopam 90 mg
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Aspirin 325 mg
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 30476529

Group type: EXPERIMENTAL
Intervention: Positive verbal feedback
Number of subjects: 90

Group type: COMPARATOR
Intervention: No verbal feedback (Control)
Number of subjects: 90
Study: 28110111

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 208
Study: 26707295

Group type: EXPERIMENTAL
Intervention: preemptive CTA (pCTA) group - donors underwent CTA at least 60 days before nephrectomy
Number of subjects: 86

Group type: COMPARATOR
Intervention: delayed CTA (dCTA) group - donors underwent CTA within 3 days before nephrectomy
Number of subjects: 86
Study: 23341426

Group type: EXPERIMENTAL
Intervention: Sulphur homeopathic remedy (6c, 12c, 30c)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Pulsatilla homeopathic remedy (6c, 12c, 30c)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Water-ethanol (95%) solution (control)
Number of subjects: 96
Study: 21813916

Group type: EXPERIMENTAL
Intervention: QC
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: QFO
Number of subjects: 39

Group type: COMPARATOR
Intervention: P
Number of subjects: 39
Study: 19089448

Group type: EXPERIMENTAL
Intervention: Family-based group treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Individual treatment
Number of subjects: 80
Study: 16816280

Group type: EXPERIMENTAL
Intervention: Psychotherapy sessions
Number of subjects: 248
Study: 15585045

Group type: EXPERIMENTAL
Intervention: 10 minutes of moderate intensity cycling (experimental)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 10 minutes of very light intensity cycling (control)
Number of subjects: 20
Study: 11265558

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 1094
Study: 9562345

Group type: EXPERIMENTAL
Intervention: Intensive therapy
Number of subjects: 1441

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 1441

Group type: COMPARATOR
Intervention: Combined cohorts (Intensive vs Conventional)
Number of subjects: 1441
Study: 9562311

Group type: EXPERIMENTAL
Intervention: Aspirin 990 mg/day + Dipyridamole 225 mg/day
Number of subjects: 1306

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1306
Study: 2708928

Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3891

Group type: EXPERIMENTAL
Intervention: Kö 1366 (bunitrolol)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31165402

Group type: EXPERIMENTAL
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 43

Group type: COMPARATOR
Intervention: LRYGB and LSG
Number of subjects: 43